BOW030 (bevacizumab biosimilar) - Epirus
FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus
Beovu (brolucizumab-dbll) - Novartis
ABP 938 (aflibercept biosimilar) - Amgen
https://www.hcplive.com/view/treat-and-extend-approach-to-anti-vegf-therapy-for-amd
 
May 24, 2021
 
Prev Next